Guangdong Zhongsheng Pharmaceutical Co Ltd (002317.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000HW4
Guangdong Zhongsheng Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.47 bn CNY | 2.52 bn CNY |
| Gross profit | 1.33 bn CNY | 1.42 bn CNY |
| Operating income | -279.95 m CNY | 320.61 m CNY |
| EBIT | 206.95 m CNY | 301.58 m CNY |
| Net income | -299.16 m CNY | 275.75 m CNY |
| Diluted EPS – continuing operations | -0.36 CNY | 0.32 CNY |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops. It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.
More stocks
- GRG Banking Equipment Co Ltd (002152.SZ)
- Apeloa Pharmaceutical Co Ltd (000739.SZ)
- AJ Bell PLC (AJB.L)
- L&K Engineering Suzhou Co Ltd (603929.SS)
- Slide Insurance Holdings, Inc. (SLDE)
- ITV PLC (ITV.L)
- Brederode SA (BREL.LU)
- Air France KLM SA (AF.PA)
- Jiangsu Nhwa Pharmaceutical Co Ltd (002262.SZ)
- AXCELIS TECHNOLOGIES INC (ACLS)
- CHESAPEAKE UTILITIES CORP (CPK)
- Takara Holdings Inc (2531.T)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.